Skip to main navigation Skip to search Skip to main content

ALEXANDRA/IMpassion030: A phase III study of standard adjuvant chemotherapy with or without atezolizumab in early-stage triple-negative breast cancer.

  • Heather L. McArthur
  • , Michail Ignatiadis
  • , Sebastian Guillaume
  • , Andrew Bailey
  • , Jorge Luis Martinez
  • , Mariana Brandao
  • , Otto Metzger
  • , Catherine Lai
  • , Debora Fumagalli
  • , Fergus Daly
  • , Aicha Bouhlel
  • , Valeria Karusinova
  • , Christie Freeman
  • , Giuseppe Viale
  • , Vanessa Honvault
  • , Carter Dufrane
  • , Anh Nguyen Duc
  • , Martine J. Piccart
  • , Eric S. Winer
  • , Richard D. Gelber

Research output: Contribution to journal › Abstract › peer-review

Original languageEnglish
Number of pages2
JournalJournal of Clinical Oncology
Volume37
Issue number15
DOIs
Publication statusPublished - 20 May 2019
EventAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO) - Chicago, Israel
Duration: 31 May 2019 → 4 Jun 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this